120 related articles for article (PubMed ID: 34477136)
1. Longitudinal assessment of amyloid-beta deposition in initially amyloid-negative non-demented individuals with [11C]-PIB PET imaging.
Hatashita S; Wakebe D
Medicine (Baltimore); 2021 Sep; 100(35):e27055. PubMed ID: 34477136
[TBL] [Abstract][Full Text] [Related]
2. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.
Okello A; Koivunen J; Edison P; Archer HA; Turkheimer FE; Någren K; Bullock R; Walker Z; Kennedy A; Fox NC; Rossor MN; Rinne JO; Brooks DJ
Neurology; 2009 Sep; 73(10):754-60. PubMed ID: 19587325
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
Hatashita S; Wakebe D
J Alzheimers Dis; 2017; 57(3):765-773. PubMed ID: 28304292
[TBL] [Abstract][Full Text] [Related]
4. Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
Hatashita S; Yamasaki H
PLoS One; 2013; 8(6):e66877. PubMed ID: 23799136
[TBL] [Abstract][Full Text] [Related]
5. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.
Kemppainen NM; Aalto S; Wilson IA; Någren K; Helin S; Brück A; Oikonen V; Kailajärvi M; Scheinin M; Viitanen M; Parkkola R; Rinne JO
Neurology; 2007 May; 68(19):1603-6. PubMed ID: 17485647
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
Okada Y; Kato T; Iwata K; Kimura Y; Nakamura A; Hattori H; Toyama H; Ishii K; Ishii K; Senda M; Ito K; Iwatsubo T;
Ann Nucl Med; 2020 Feb; 34(2):108-118. PubMed ID: 31749127
[TBL] [Abstract][Full Text] [Related]
7. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
[TBL] [Abstract][Full Text] [Related]
8. Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.
Tian Q; Bilgel M; Moghekar AR; Ferrucci L; Resnick SM
J Alzheimers Dis; 2022; 86(3):1275-1285. PubMed ID: 35180111
[TBL] [Abstract][Full Text] [Related]
9. Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging.
Hatashita S; Yamasaki H
J Alzheimers Dis; 2010; 21(3):995-1003. PubMed ID: 20693641
[TBL] [Abstract][Full Text] [Related]
10. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer's Disease.
Hatashita S; Wakebe D; Kikuchi Y; Ichijo A
Front Aging Neurosci; 2019; 11():251. PubMed ID: 31572167
[TBL] [Abstract][Full Text] [Related]
12. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
[TBL] [Abstract][Full Text] [Related]
13. Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET Threshold.
Ismail R; Parbo P; Hansen KV; Schaldemose JL; Dalby RB; Tietze A; Kjeldsen PL; la Cour SH; Qvist P; Gottrup H; Eskildsen SF; Brooks DJ
J Neuroimaging; 2019 Jul; 29(4):499-505. PubMed ID: 31074062
[TBL] [Abstract][Full Text] [Related]
14. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.
Byun BH; Kim BI; Park SY; Ko IO; Lee KC; Kim KM; Kim YK; Lee JY; Bu SH; Kim JH; Chi DY; Ha JH; Lim SM
Medicine (Baltimore); 2017 Mar; 96(12):e6441. PubMed ID: 28328855
[TBL] [Abstract][Full Text] [Related]
16. β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies.
Diaz-Galvan P; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Min HP; Jain M; Miyagawa T; Forsberg LK; Fields JA; Savica R; Graff-Radford J; Jones DT; Botha H; St Louis EK; Knopman DS; Ramanan VK; Ross O; Graff-Radford N; Day GS; Dickson DW; Ferman TJ; Petersen RC; Lowe VJ; Boeve BF; Kantarci K
Neurology; 2023 Jul; 101(2):e178-e188. PubMed ID: 37202168
[TBL] [Abstract][Full Text] [Related]
17. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
18. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A
J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821
[TBL] [Abstract][Full Text] [Related]
19. Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.
Raji CA; Becker JT; Tsopelas ND; Price JC; Mathis CA; Saxton JA; Lopresti BJ; Hoge JA; Ziolko SK; DeKosky ST; Klunk WE
J Neurosci Methods; 2008 Jul; 172(2):277-82. PubMed ID: 18582948
[TBL] [Abstract][Full Text] [Related]
20. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]